首页|视听性刺激勃起检测对勃起功能障碍的诊断价值分析

视听性刺激勃起检测对勃起功能障碍的诊断价值分析

扫码查看
目的 探讨在诊断勃起功能障碍(ED)时应用视听性刺激检测(AVSS)的价值。方法 选取2021年1月至2022年6月上饶市人民医院泌尿男科收治的67例疑似勃起功能障碍患者作为研究对象,所有患者均行AVSS。以夜间勃起功能和硬度检查(NPTR)为金标准,比较AVSS与NPTR鉴别诊断不同类型ED检出率,记录AVSS诊断的敏感度、特异度、阳性预测值、阴性预测值、准确率及Kappa值,比较两种检查方法的检测用时及检测费用。结果 NRTR诊断器质性ED检出27例,心理性ED 40例;AVSS诊断器质性ED 28例、误诊2例,心理性ED 39例,误诊1例。AVSS诊断ED准确率为95。52%,AUC为0。912;且AVSS与NPTR诊断器质性ED的一致性较好(Kappa=0。908,P<0。05);AVSS的检测用时、检测费用低于NPTR,差异有统计学意义(P<0。05)。结论 AVSS可作为初筛手段,经济、便捷、迅速,值得临床推广。
Analysis of diagnostic value of audiovisual sexual stimulation for erectile dysfunction
Objective To analyze the value of audiovisual sexual stimulation(AVSS)for erectile dysfunction(ED).Methods A total of 67 patients with suspected ED admitted to Department of Urology and Andrology,ShangRao People's Hospital from January 2021 to June 2022 were selected as the study subjects.All patients underwent AVSS,nocturnal penile tumescence and rigidity(NPTR)was used as the gold standard.The detection rates of AVSS and NPTR in the differential diagnosis of different types of erectile dysfunction were compared.The sensitivity,specificity,positive predictive value,negative predictive value,accuracy and Kappa value of AVSS were recorded.The test time and cost of the two methods were compared.Results NRTR diagnosed 27 cases of organic ED and 40 cases of psychological ED.AVSS diagnosed 28 cases of organic ED and misdiagnosed 2 cases,39 cases of psychological ED and misdiagnosed 1 case.The accuracy of AVSS in the diagnosis of ED was 95.52%,and AUC was 0.912,and the consistency between AVSS and NPTR in the diagnosis of organic ED was good(Kappa=0.908,P<0.05).The test time and cost of AVSS were lower than those of NPTR,and the differences were statistically significant(P<0.05).Conclusion AVSS can be used as a primary screening method,which is economical,convenient,and rapid,and is worthy of clinical promotion.

Audio-visual stimulationErectile detectionErectile dysfunctionDiagnostic value

朱晓东、徐绍洪、吴杰、钟德平、郑增斌、梅烁

展开 >

江西省上饶市人民医院泌尿男科,江西上饶 334000

视听性刺激 勃起检测 勃起功能障碍 诊断价值

江西省卫生健康委科技计划项目

202140931

2024

中国当代医药
中国保健协会 当代创新(北京)医药科学研究院

中国当代医药

影响因子:1.215
ISSN:1674-4721
年,卷(期):2024.31(7)
  • 20